Free EBook: 15 Industry insights into how vaccine sponsors choose CROs 17 June 2013 / By Freya Smale / Partnering and Corporate strategy / 0 comments
MenAfriVac drives down meningitis A cases to 10-year low 7 June 2013 / By Tim / Featured on App, Prophylactic Vaccines / 0 comments
GSK buys Okairos for $324 million in vaccine boost effort 29 May 2013 / By Tim / Featured on App, Partnering and Corporate strategy, Prophylactic Vaccines, R&D / 0 comments
Nanoparticle universal flu vaccine “may be up for grabs” 24 May 2013 / By Tim / Featured on App, Flu, Prophylactic Vaccines, R&D / 0 comments
Sanofi’s new QIV may earn up to $384m in 2022 13 June 2013 / By Tim / Featured on App, Flu / 0 comments
Aedes Aegypti: the dengue mosquito in action 12 June 2013 / By Tim / Featured Videos, Featured on App, Prophylactic Vaccines / 0 comments
Sanofi nabs quadrivalent flu vaccine FDA approval for under 2s 11 June 2013 / By Tim / Featured on App, Flu, Regulation and Policy / 0 comments
Medicago “first in the world” to report positive pre-clinical data for H7N9 vaccine 11 June 2013 / By Tim / Featured on App, Flu, Prophylactic Vaccines, R&D / 2 comments
Download presentation: EMA regulatory activities in the area of vaccines: an update 10 June 2013 / By Freya Smale / Featured on App, Regulation and Policy / 0 comments
TeloVac Phase III cancer vaccine trial disappoints, but not without silver linings 5 June 2013 / By Tim / Featured on App, R&D, Therapeutic Vaccines / 1 comment
Cattle vaccine delivery system 4 June 2013 / By Tim / Featured Videos, Featured on App, Veterinary Vaccines / 0 comments
Engineering a bacterial antigen and DNA vaccine delivery system – Dr Wei Kong 4 June 2013 / By Tim / Featured Videos, Featured on App / 0 comments
